Drug Channels
FEBRUARY 22, 2022
On March 15, 2022, Drug Channels Institute will release The 2022 Economic Report on U.S. We are providing you with the opportunity to preorder this thoroughly updated, revised, and expanded 2022 edition at special discounted prices. Special preorder and launch pricing discounts will be valid through March 28, 2022.
Drug Patent Watch
DECEMBER 10, 2024
billion in 2022 and is expected to grow at a compound annual growth rate of 5.3% ” – Patheon “By possessing a deeper understanding of the regulations that apply to each step of the development and manufacturing journey, embedded CDMOs can often anticipate questions and issues that might arise and help avoid costly delays.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
DECEMBER 11, 2024
Pharmaceutical companies should evaluate a CDMOs compliance with industry standards and regulations, ensuring that they have a robust quality assurance system in place. 2022, November 29). Regulatory Compliance and Quality Assurance Regulatory compliance and quality assurance are essential aspects of CDMO selection.
Advarra
NOVEMBER 10, 2022
On September 28, 2022, the Food and Drug Administration (FDA) released two Notices of Proposed Rulemaking (NPRM). In addition to the harmonization goal, these additional elements help modernize the regulations with current scientific and participant expectations. . Again, this is similar to what HHS regulations currently permit. .
Chemical Biology and Drug Design
MAY 25, 2023
PTP1B is a negative insulin signaling pathway regulator; hence, inhibiting PTP1B increases insulin sensitivity, glucose absorption, and energy expenditure. PTP1B is a negative insulin signaling pathway regulator; hence, inhibiting PTP1B increases insulin sensitivity, glucose absorption, and energy expenditure.
Drug Channels
FEBRUARY 7, 2022
Hybrid Event March 28-29, 2022 | Philadelphia, PA www.informaconnect.com/drug-pricing-transparency. Don’t miss the Drug Pricing Transparency Congress on March 28-29, 2022! Drug Channels readers will save 10% off when they use promo code 22DRCH10 and register prior to March 4, 2022.*. Drug Pricing Transparency Congress.
The Pharma Data
MARCH 31, 2022
L’Oréal, Sanofi’s largest shareholder, has committed to a lock-up period of 1 year following the settlement of the Distribution, i.e., May 10, 2022. cash dividend per Sanofi share. For information on the tax treatment of the Distribution, shareholders are invited to read Paragraph 22.1.6 of the listing prospectus.
Expert insights. Personalized for you.
96 
Let's personalize your content